This is a match-making section for JPIAMR 17th call - AMR Interventions 2024 (IMPACT).
Human Health
Animal Health (incl. wildlife, livestock, acquatic organisms, and companion animals)combination therapy; antimicrobial peptides; polymers; drug delivery; fungal eye infections
My group works at the interface of organic/polymer chemistry, nanotechnology, materials science and microbiology. We have expertise in the field of developing antimicrobial peptide mimics either as sole antimicrobial agent or as adjuvants in combination therapy to repurpose/revive the activity of antibiotics that are no longer effective against multidrug-resistant bacteria. We have several publications in this field, please kindly check our group website.
We are hoping to build upon this project and I have another collaborator here in Australia who could do in vivo animal models for eye fungal infection. The idea is to screen for many other compounds out there besides ours for new synergy combinations that could repurpose ineffective antibiotics/antifungals. It will be great if there are others here who are either working on antimicrobial peptide mimics, combination therapy, in vivo fungal infection models, mechanism understanding to determine why and how the adjuvant is reviving the susceptibility of the drugs.
Submitted on 2024-01-25 09:19:05
« Return to the partner search tool